Eulogio Gil-Neciga
Overview
Explore the profile of Eulogio Gil-Neciga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Firth N, Primativo S, Marinescu R, Shakespeare T, Suarez-Gonzalez A, Lehmann M, et al.
Brain
. 2019 Jun;
142(7):2082-2095.
PMID: 31219516
Posterior cortical atrophy is a clinico-radiological syndrome characterized by progressive decline in visual processing and atrophy of posterior brain regions. With the majority of cases attributable to Alzheimer's disease and...
2.
Suarez-Gonzalez A, Lehmann M, Shakespeare T, Yong K, Paterson R, Slattery C, et al.
Neurobiol Aging
. 2016 Jun;
44:108-113.
PMID: 27318138
Age at onset (AAO) has been shown to influence the phenotype of Alzheimer's disease (AD), but how it affects atypical presentations of AD remains unknown. Posterior cortical atrophy (PCA) is...
3.
Schott J, Crutch S, Carrasquillo M, Uphill J, Shakespeare T, Ryan N, et al.
Alzheimers Dement
. 2016 Mar;
12(8):862-71.
PMID: 26993346
Introduction: The genetics underlying posterior cortical atrophy (PCA), typically a rare variant of Alzheimer's disease (AD), remain uncertain. Methods: We genotyped 302 PCA patients from 11 centers, calculated risk at...
4.
Suarez-Gonzalez A, Crutch S, Franco-Macias E, Gil-Neciga E
J Geriatr Psychiatry Neurol
. 2015 Sep;
29(2):65-71.
PMID: 26404166
Background: Posterior cortical atrophy (PCA) is a rare neurodegenerative syndrome characterized by early progressive visual dysfunction in the context of relative preservation of memory and a pattern of atrophy mainly...
5.
Suarez-Gonzalez A, Green Heredia C, Savage S, Gil-Neciga E, Garcia-Casares N, Franco-Macias E, et al.
Neurocase
. 2014 Mar;
21(3):309-21.
PMID: 24592963
Patients with semantic dementia (SD) may undergo successful relearning of object names, but these gains are usually restricted to the trained exemplars, demonstrating poor generalization. We hypothesized that generalization could...
6.
Suarez-Gonzalez A, Serrano-Pozo A, Arroyo-Anllo E, Franco-Macias E, Polo J, Garcia-Solis D, et al.
Int Psychogeriatr
. 2013 Nov;
26(3):453-61.
PMID: 24284139
Background: Discerning dementia with Lewy bodies (DLB) from Alzheimer's disease (AD) is one of the most common and challenging differential diagnoses at the memory clinic. Although the neuropsychiatric manifestations have...
7.
Palomar F, Suarez A, Franco E, Carrillo F, Gil-Neciga E, Mir P
J Neurol Neurosurg Psychiatry
. 2013 Jan;
84(3):329-36.
PMID: 23308019
Objective: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a small vessel disease of the brain caused by mutations in the NOTCH3 gene. CADASIL progresses, in some...
8.
Gomez-Tortosa E, Gallego J, Guerrero-Lopez R, Marcos A, Gil-Neciga E, Sainz M, et al.
Neurology
. 2013 Jan;
80(4):366-70.
PMID: 23284068
Objective: Expansions of more than 30 hexanucleotide repetitions in the C9ORF72 gene are a common cause of frontotemporal dementia (FTD) or amyotrophic lateral sclerosis (ALS). However, the range of 20-30...
9.
Hita-Yanez E, Atienza M, Gil-Neciga E, Cantero J
Curr Alzheimer Res
. 2012 Jan;
9(3):290-7.
PMID: 22211488
Sleep disturbances are prevalent in patients with Alzheimer' disease (AD), being one of the most troubling symptoms during the progression of disease. However, little research has been made to determine...
10.
Gomez-Tortosa E, Barquero S, Baron M, Gil-Neciga E, Castellanos F, Zurdo M, et al.
J Alzheimers Dis
. 2010 Feb;
19(3):873-84.
PMID: 20157243
We describe the clinical phenotype of nine kindred with presenile Alzheimer's disease (AD) caused by different presenilin 1 (PS1) point mutations, and compare them with reported families with mutations in...